People · Operator
Named in public records as an officer, director or promoter · active 2008–2022 · Biotechnology, Pharmaceuticals, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tectonic Therapeutic, Inc. | — | Biotechnology | Series D+ | $333.1M | $1.7B | 2016 |
| Unum Therapeutics Inc. | — | Biotechnology | Series D+ | $220.5M | $4.3B | 2014 |
| Vigil Neuroscience, Inc. | — | Pharmaceuticals | Series C | $215.0M | $1.3B | 2020 |
| Larimar Therapeutics, Inc. | — | Biotechnology | Series C | $201.0M | $3.3B | 2012 |
| Miragen Therapeutics, Inc. | — | Biotechnology | Series C | $197.8M | $3.3B | 2008 |
| Magenta Therapeutics, Inc. | — | Biotechnology | Series C | $116.0M | $2.1B | 2016 |
| Avila Therapeutics Inc | — | Biotechnology | Series B | $45.0M | $893.0M | 2009 |
| Matchpoint Therapeutics Inc. | — | Pharmaceuticals | Series C | $42.0M | $672.3M | 2022 |
| Lysosomal Therapeutics, Inc. | — | Biotechnology | Series B | $38.0M | $39.7M | 2015 |
| Rodin Therapeutics, Inc. | — | Pharma | Series A | $10.8M | $335.3M | 2017 |
| Numerate Inc | — | Biotechnology | Series A | $8.2M | $297.9M | 2014 |
| Nimbus Discovery, LLC | — | Pharmaceuticals | Seed | $5.0M | $57.1M | 2010 |
Bruce Booth at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bruce Booth on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Clay Thorp | 2 | 10 |
| Vicki Sato | 2 | 6 |
| Bruce L Booth | 2 | 2 |
| Bruce S. Booth | 2 | 2 |
| Peter Barrett | 1 | 18 |
| Amir Nashat | 1 | 14 |
| Joshua Resnick | 1 | 12 |
| Jonathan Leff | 1 | 11 |
| Kyle Lefkoff | 1 | 9 |
| Ben Auspitz | 1 | 9 |
| Terry McGuire | 1 | 8 |
| John Davis | 1 | 7 |
| Mitchell S. Bloom | 1 | 7 |
| Andre Turenne | 1 | 7 |
| Daniel Lynch | 1 | 7 |
| John Griffin | 1 | 6 |
| Alexis Borisy | 1 | 6 |
| Daniel Geffken | 1 | 6 |
| Adam Rosenberg | 1 | 6 |
| Mitchell Bloom | 1 | 6 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.